ADVANCES IN THE MANAGEMENT OF ULCERATIVE COLITIS

PFIZER, S.A

Object

Topic: Gastroenterology.

Destination: This competitive grant program seeks to improve healthcare professional understanding of Sphingosine-1-phosphate (S1P) receptor modulation in the treatment of UC. Projects that will be considered for Pfizer support will focus on providing education to healthcare professionals (HCPs) involved in diagnosis, treatment, and management of patients with UC.

Budget: Up to $150,000/project.

Duration: Up to 3 years.

Are you interested in this call?

Are you interested?

Fill out the form below to receive more information: